BioSpace News Archive

Baxter today announced a distribution agreement for the U.S. launch of the Arisure Closed System Transfer device.

CLSA today issued the following statement applauding Governor Jerry Brown’s 2018 - 2019 California budget proposal that calls for $30M to be invested in precision medicine research and the establishment of the CIAPHM.

TECHLAB today announced that Phoenix Lab will be one of the first veterinary reference labs in the Pacific Northwest to offer the GIARDIA VET CHEK test to its customers.

Under the collaboration, PREMIER Biosoft and Dr. Francisco Fernandez-Lima, from the Biomolecular Sciences Institute at Florida International University will work closely to power research in small as well as large molecule identification and quantification.

BioIVT’s eminent and world-renowned SAB members will provide the company with scientific and business insights and help it to identify future growth areas.

Adimab announced that six new partner programs entered clinical trials in 2017.

Tenet Diagnostics (Tenet), providers of high-quality laboratory and genomic testing and evidence-based research designed to direct patient care for clinicians, employers and payers, announces the release of its white paper, “Economic Value of Drug Testing in the Workplace for Health Payers & Employers.”

Jan. 11, 2018 11:00 UTC Innovus Pharma Announces U.S. Food and Drug Administration Clearance of Its UriVarx® Urinary Tract Infection Test Strips Company Expects Sales of Its UriVarx ® Franchise to Increase With Addition of UTI Test Strips SAN DIEGO--( BUSINESS WIRE )-- Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical co

In this capacity, Dr. Nathan will work with the Company to help guide its efforts to develop FDA-approved drugs for the protection of warfighters.

Can-Fite announced its near-term milestones for 2018, including events related to the rheumatoid arthritis/psoriasis drug Piclidenoson and the liver disease drug Namodenoson.